An FDA advisory panel will be voting on whether or not Purdue Pharma's abuse-deterrent formulation (ADF) of oxycodone (OxyContin) "meaningfully reduced" opioid-related overdoses and deaths since it was introduced in the market 10 years ago.
Opioid crisis deepens during the COVID-19 lockdown
Opioid deaths have surged across the United States during the spread of the coronavirus pandemic; the strict lockdown measures have put many Americans out of work and taken away patients from necessary medical and mental health care.
HHS released a proposed rule allowing to import drugs from Canada to lower prices for consumers
The Department of Health and Human Services has proposed a rule to lower the prices of drugs for consumers by allowing pharmaceutical manufacturers to import certain prescription drugs from Canada.
Federal officials warn Colorado residents that establishing a supervised drug-use site in Denver could be illegal
Federal officials warned Colorado residents that establishing a supervised drug-use site in Denver could have legal consequences.
Trump’s blueprint to combat rising drug costs
In a bold move President Trump unveiled the blue print of the plan to lower prescription drug prices. He proposes to bring down the costs at home by negotiating with other foreign countries to pay higher prices.